Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: A Calcium Channelopathy?

Affiliations

Comment

Carl E Stafstrom. Epilepsy Curr. 2024.

. 2024 Apr 30;24(3):191-193.

doi: 10.1177/15357597241249045. eCollection 2024 May-Jun.

No abstract available

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability.
Sampedro-Castañeda M, Baltussen LL, Lopes AT, Qiu Y, Sirvio L, Mihaylov SR, Claxton S, Richardson JC, Lignani G, Ultanir SK. Sampedro-Castañeda M, et al. Nat Commun. 2023 Dec 11;14(1):7830. doi: 10.1038/s41467-023-43475-w. Nat Commun. 2023. PMID: 38081835 Free PMC article.

1. Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev. 2023;103(1):433–513. - PMC - PubMed
1. Van Bergen NJ, Massey S, Quigley A, et al. CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development. Biochem Soc Trans. 2022;50(4):1207–1224. - PMC - PubMed
1. Leonard H, Downs J, Benke TA, Swanson L, Olson H, Demarest S. CDKL5 deficiency disorder: clinical features, diagnosis, and management. Lancet Neurol. 2022;21(6):563–576. - PMC - PubMed
1. Dell’Isola GB, Portwood KE, Consing K, et al. Current overview of CDKL-5 deficiency disorder treatment. Pediatr Rep. 2024;16(1):21–25. - PMC - PubMed
1. Olson HE, Amin S, Bahi-Buisson N, et al. Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: two-year open-label extension follow-up. Epilepsia. 2024;65(1):37–45. - PubMed